{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:41:23Z","timestamp":1778812883753,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.09.069","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T07:31:18Z","timestamp":1665041478000},"page":"7201-7210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-9487","authenticated-orcid":false,"given":"Asia-Sophia","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mitsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4835-1032","authenticated-orcid":false,"given":"Simon P.","family":"Jochems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Roalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deus","family":"Thindwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-5174","authenticated-orcid":false,"given":"James E.","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquline","family":"Msefula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farouck","family":"Bonomali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tikhala","family":"Makhaza Jere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Mbewe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melita A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-5242","authenticated-orcid":false,"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-7039","authenticated-orcid":false,"given":"Todd D.","family":"Swarthout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.069_b0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.09.069_b0010","unstructured":"World Health Organisation. WHO vaccine-preventable diseases: monitoring system. 2020 global summary. Available at: https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules. Accessed 4 December 2020."},{"key":"10.1016\/j.vaccine.2022.09.069_b0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0025","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1016\/j.vaccine.2019.09.079","article-title":"Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern Mozambique","volume":"37","author":"Massora","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","article-title":"Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study","volume":"16","author":"Mackenzie","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.201503-0542OC","article-title":"First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial","volume":"192","author":"Collins","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2022.09.069_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12916-019-1450-2","article-title":"Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study","volume":"17","author":"Lourenco","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2022.09.069_b0045","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/cix895","article-title":"Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries","volume":"66","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0050","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1016\/j.vaccine.2015.11.012","article-title":"Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the expanded programme of immunization in the Gambia","volume":"33","author":"Roca","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0055","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/s41467-020-15786-9","article-title":"High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi","volume":"11","author":"Swarthout","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.09.069_b0060","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.vaccine.2014.12.023","article-title":"Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age","volume":"33","author":"Nunes","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0065","doi-asserted-by":"crossref","unstructured":"Bar-Zeev N, Swarthout TD, Everett DB, et al. Impact and Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine on Population Incidence of Vaccine and Non-Vaccine Serotype Invasive Pneumococcal Disease in Blantyre, Malawi, 2006-2018: Prospective Observational Time-Series and Case-Control Studies. SSRN Electronic Journal 2020.","DOI":"10.2139\/ssrn.3745169"},{"key":"10.1016\/j.vaccine.2022.09.069_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00438-8","article-title":"Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study","author":"Swarthout","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0075","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1172\/JCI128865","article-title":"Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization","volume":"129","author":"Jochems","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2022.09.069_b0080","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0085","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0090","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/513199","article-title":"Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine","volume":"44","author":"Millar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokinen","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0105","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.069_b0110","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1164\/rccm.201512-2467OC","article-title":"Polysaccharide-specific memory B cells predict protection against experimental human pneumococcal carriage","volume":"194","author":"Pennington","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2022.09.069_b0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/mi.2016.71","article-title":"Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage","volume":"10","author":"Mitsi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0120","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.4049\/jimmunol.170.12.6158","article-title":"Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice","volume":"170","author":"Saeland","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0130","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1128\/IAI.67.9.4935-4938.1999","article-title":"Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination","volume":"67","author":"Lottenbach","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.069_b0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/cdli.4.2.168-172.1997","article-title":"Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria","volume":"4","author":"Rodrigo","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0140","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.vaccine.2006.03.088","article-title":"Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity","volume":"24","author":"Uddin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0145","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes","volume":"8","author":"Grant","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.069_b0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jim.2018.08.002","article-title":"Measuring immune responses to pneumococcal vaccines","volume":"461","author":"LaFon","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2022.09.069_b0155","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/CVI.00039-13","article-title":"Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy","volume":"20","author":"Ekstr\u00f6m","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0165","doi-asserted-by":"crossref","first-page":"e0144739","DOI":"10.1371\/journal.pone.0144739","article-title":"Direct comparison of immunogenicity induced by 10- or 13-valent pneumococcal conjugate vaccine around the 11-month booster in Dutch infants","volume":"10","author":"Wijmenga-Monsuur","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.069_b0170","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0175","doi-asserted-by":"crossref","first-page":"e016283","DOI":"10.1136\/bmjopen-2017-016283","article-title":"The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys","volume":"7","author":"Darton","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2022.09.069_b0180","doi-asserted-by":"crossref","DOI":"10.3791\/50115-v","article-title":"Experimental human pneumococcal carriage","author":"Gritzfeld","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2022.09.069_b0185","first-page":"514","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0190","doi-asserted-by":"crossref","unstructured":"Jones S, Finnegan K, Wee JH, et al. Assignment of Serotype-Specific IgG1, IgG2, and IgA Weight-Based Antibody Units to the Human Pneumococcal Standard Reference Serum, 007sp. mSphere 2019; 4.","DOI":"10.1128\/mSphere.00400-19"},{"key":"10.1016\/j.vaccine.2022.09.069_b0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies","volume":"13","author":"Burton","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0200","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10875-013-9870-9","article-title":"Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics","volume":"33","author":"Fried","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0205","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/315798","article-title":"Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants","volume":"182","author":"Spoulou","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0210","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/515298","article-title":"Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines","volume":"177","author":"Anttila","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0215","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/CVI.00147-14","article-title":"Avidity of antibodies against infecting pneumococcal serotypes increases with age and severity of disease","volume":"21","author":"Cremers","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0220","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1128\/CVI.00248-12","article-title":"Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine","volume":"19","author":"Simell","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0225","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1016\/j.vaccine.2013.09.073","article-title":"Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose","volume":"31","author":"van Westen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0230","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1016\/j.vaccine.2011.04.038","article-title":"Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months","volume":"29","author":"Russell","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/CVI.00654-15","article-title":"Poor correlation between pneumococcal IgG and IgM titers and opsonophagocytic activity in vaccinated patients with multiple myeloma and waldenstrom's macroglobulinemia","volume":"23","author":"Karlsson","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.09.069_b0240","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/j.vaccine.2017.05.088","article-title":"Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage","volume":"35","author":"Ojal","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.069_b0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cid\/ciaa083","article-title":"Carrier-induced hyporesponsiveness to pneumococcal conjugate vaccines: unraveling the influence of serotypes, timing, and previous vaccine dose","volume":"72","author":"Dagan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.069_b0250","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/IAI.69.1.336-344.2001","article-title":"Potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B","volume":"69","author":"Sun","year":"2001","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:20:50Z","timestamp":1759404050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":50,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X22011902"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}